Ren, M., Qin, H., Ren, R., & Cowell, J. K. (2012). Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities.
Citação norma ChicagoRen, Mingqiang, Haiyan Qin, Ruizhe Ren, and John K. Cowell. Ponatinib Suppresses the Development of Myeloid and Lymphoid Malignancies Associated With FGFR1 Abnormalities. 2012.
ציטוט MLARen, Mingqiang, Haiyan Qin, Ruizhe Ren, and John K. Cowell. Ponatinib Suppresses the Development of Myeloid and Lymphoid Malignancies Associated With FGFR1 Abnormalities. 2012.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.